Background-It is unknown whether hospitals with percutaneous coronary intervention (PCI) capability provide costlier care than hospitals without PCI capability for patients with acute myocardial infarction. The growing number of PCI hospitals and higher rate of PCI use may result in higher costs for episodes-of-care initiated at PCI hospitals. However, higher rates of transfers and postacute care procedures may result in higher costs for episodes-of-care initiated at non-PCI hospitals. 
H ospitalizations for acute myocardial infarctions (AMI) are common and costly. Percutaneous coronary intervention (PCI) is a major contributor to the cost of treating patients with AMI. In recent years, hospitals have increasingly established new PCI programs, with an expansion of PCI hospitals, in the United States, of ≈16.5% from 2004 to 2008. 1 This increase in the number of PCI hospitals could have implications for both the quality and cost of care for patients with AMI. Although several recent studies have examined whether increased PCI capability improves access or outcomes, [1] [2] [3] [4] [5] [6] [7] [8] little is known about the cost of treatment for patients admitted with AMI at PCI hospitals versus non-PCI hospitals. This group has previously found that hospital costs for patients admitted to facilities with and without catheterization capabilities did not differ substantially. 8 However, this work was done for patients admitted between 1992 and 1993 in a single state; to our knowledge, there have been no recent comparisons of hospital costs for patients with AMI admitted to PCI versus non-PCI facilities and no such studies done on a national level.
Admission to PCI hospitals may be associated with higher costs for patients with AMI because of higher rates of inpatient procedures compared with non-PCI hospitals.
Alternatively, non-PCI hospitals may be associated with higher costs for patients with AMI for several reasons. For example, admissions to non-PCI hospitals that require transfer to PCI hospitals for urgent procedures result in 2 payments from health insurers, 1 for each admission. In addition, patients discharged from non-PCI hospitals without transfer for PCI may later undergo PCI during subsequent admissions or in the outpatient setting. In fact, the costs associated with transfers and deferred procedures for patients admitted to non-PCI hospitals may balance the cost associated with higher procedure rates at PCI hospitals. Understanding the differences in cost of care at PCI hospitals versus non-PCI hospitals may inform practices and policies influencing the conversion of non-PCI hospitals to PCI hospitals. Accordingly, we sought to characterize the cost of acute episodes-of-care provided by PCI versus non-PCI hospitals for Medicare patients presenting with an AMI. We compared payments made at the hospital-level for Medicare patients for a 30-day episode-of-care to account for the costs of both hospitalizations in the case of a transfer and the costs of follow-up care, including nonacute procedures. In an effort to better understand the reasons underlying hospital-level costs of care, we also conducted secondary patient-level analyses examining rates of patient transfer and coronary revascularization, including both PCI and coronary artery bypass graft (CABG) surgery, for patients presenting to PCI and non-PCI hospitals.
Methods

Data Sources
To identify our cohort, we used the 2008 Chronic Condition Warehouse data set of Medicare administrative claims to identify 100% of fee-for-service beneficiaries who were ≥65 years and had an inpatient admission with a principal discharge diagnosis of AMI as identified using 
Cohort
The study cohort included Medicare fee-for-service beneficiaries, aged ≥65 years, hospitalized between January 1 and December 31, 2008, with a principal discharge diagnosis of AMI as defined above. We required that all patients had both part A and part B coverage in the year prior to index admission and during the 30-day episode-ofcare payment window. We excluded patients who were discharged on the same or next day and did not die or get transferred, patients with inconsistent or unknown vital status, patients with unreliable data, patients who discharged against medical advice, hospice patients, patients transferred to federal hospitals, and patients with missing Medicare-Severity Diagnosis Related Group code or MedicareSeverity Diagnosis Related Group weight. For patients with multiple hospitalizations during this time frame, we randomly selected 1 hospitalization per patient.
Hospital Classification
We classified hospitals as PCI-or non-PCI-capable on the basis of evidence that they performed PCIs in the year before the index admission. Using billing, we defined PCI hospitals as those hospitals that had billed Medicare for ≥10 PCI procedures in 2007, using ICD-9 procedure codes 36.01, 36.02, 36.05, 36.06, 36.07, 00.66, and 17.55 for PCI. Hospitals for which PCI status could not be determined (eg, those with new hospital identities in 2008) were excluded from the analysis (n=13 hospitals).
Primary Outcome
Our primary outcome was 30-day episode-of-care risk-standardized payments (RSPs) at the hospital level. We calculated total payment for the 30-day episode-of-care by summing all payments from the time of index admission through 30 days post admission. We chose 30 days because it is a preset window, which is consistent with publicly reported outcome measures from CMS and is likely to capture associated follow-up care for AMI. For patients who were transferred, we considered the consecutive hospitalizations as a single admission with the 30-day episode beginning with the index admission. All payments for Medicare patients incurred during the second admission as well as during the full 30-day episode were attributed to the initial admitting hospital, constituting 1 episode-of-care.
We used publicly available fee schedules from CMS to calculate payments for claims that occurred in care settings reimbursed under a fee schedule. Reimbursement rates and weights for each care setting were from fiscal year, rate year, or calendar year 2008 or 2009 depending on the care setting, and were identified in either Final Rules published in the Federal Register or fee schedules listed on the CMS Web site. For those care settings not reimbursed using a CMS fee schedule, we obtained the data necessary to calculate payments from applicable CMS Final Rules or via the CMS website (eg, base payments and conversion factors, Medicare-Severity Diagnosis Related Group weights, wage indexes, and average length of stay). We also used the Medicare Enrollment Database to obtain information on enrollment, date of birth, and postdischarge mortality status.
WHAT IS KNOWN
• Previous studies have shown that patients presenting to percutaneous coronary intervention (PCI) hospitals undergo more procedures than those presenting to non-PCI hospitals, with uncertain improvement in clinical outcomes. Studies have also shown that the growing number of PCI hospitals has not improved access to PCI for patients.
• Work done in a limited cohort has previously demonstrated no significant difference in hospital costs for patients admitted to facilities with and without catheterization capabilities.
WHAT THE STUDY ADDS
• In a national sample, despite higher procedure rates for patients presenting to PCI hospitals, overall episode-of-care payments for patients presenting to PCI hospitals are only slightly more costly that for patients presenting to non-PCI hospitals with acute myocardial infarction.
Standardizing Payments
For each care setting, we standardized payments by calculating a payment that removes the influence of Medicare geographic and policy adjustments to isolate the portion of payment that reflects care decisions. Medicare reimburses providers using several different mechanisms depending on the care setting. We have provided details on the calculation of acute inpatient payments and analogous calculations for all other settings in the Data Supplement. When the data did not allow for the removal of geographic adjustments, we used the CMS fee schedule data to calculate an average payment and uniformly applied it across all geographic areas. For example, for laboratory services, where Medicare reimburses each state at different amounts, we averaged the payment for an item across all states and replaced the state-specific payment amount for that item in a patient's claim with the average payment.
We then arrived at a total payment for each episode-of-care by summing our standardized payments for all applicable care settings during a patient's 30-day episode-of-care. We included payments that began during a patient's 30-day episode-of-care but ended after by applying a prorated amount. For example, if a patient was admitted to a skilled nursing facility on day 25 of the episode-of-care window and remained in the facility until day 40, we calculated the payment for the entire 16-day period and then divided it by 16 to obtain a daily payment amount. We then multiplied that amount by the number of days the patient was in the care setting during the 30-day episode-ofcare payment window (6 in the example above).
Calculating RSPs
We calculated RSP for each hospital using 2-level hierarchical generalized linear models that adjust for patient demographics, such as age and clinical characteristics, including comorbid conditions identified in claims for acute inpatient hospital stays, hospital outpatient care, and physician, radiology, and laboratory services for 12 months before the index admission as well as select conditions indicated by secondary diagnoses codes on index admission. Hospital-level random intercepts were included to account for the clustering, or nonindependence, of patients within hospitals, and to capture hospital-level signal.
We used CMS Condition Category groups to define the comorbid risk-adjustment variables. Candidate risk-adjustment variables were selected for the model on the basis of clinical coherence and strength of association in the same manner as for the CMS AMI mortality measure. 9 We then selected final risk-adjustment variables by bootstrapping multiple stepwise regressions and included those variables that came into the model >90% of the time. We did not risk adjust for diagnoses that may have been complications of care during the index admission because, although complications may contribute to higher costs and payments, they represent potential differences in payment that are influenced by hospital actions, and such differences should be captured by the payment measurement. In addition, we risk adjusted for the patients' age and their history of PCI and CABG. We have provided the final risk-adjustment variables included in the RSP model and their coefficient estimates in Table IA in the Data Supplement.
We used the following strategy to calculate the hospital-specific RSPs. We calculated these payments as the ratio of predicted AMI payment to expected AMI payment, and multiplied by the national unadjusted average AMI payment. The predicted AMI payment for each hospital was estimated using its patient mix and an estimated hospital-specific intercept. The expected AMI payment for each hospital was estimated given the same patient mix but the average intercept among all hospitals in the sample.
Secondary Outcomes
We calculated transfer rates, rates of PCI and CABG, and revascularizations that followed the inpatient admission (subsequent revascularizations), including PCI and CABG performed during readmissions and PCI performed in the outpatient setting within 30 days of admission for patients who began their episode-of-care at PCI and non-PCI hospitals. We defined transferred patients as those patients who were either transferred between hospitals or discharged from 1 acute-care hospital and admitted to a different acute-care hospital on the same or next day, regardless of the discharge disposition listed on the claim. In addition, we calculated unadjusted patient-level payments, including mean total payments, index hospital payments, and postacute care payments for patients presenting to PCI and non-PCI hospitals. We further categorized postacute care payments as payments for readmissions, skilled nursing facilities, other inpatient payments (including inpatient psychiatry, rehabilitation, and long-term care hospitals), outpatient hospital payments, and home health payments. These payments were adjusted to remove payments related to CMS geographic and policy factors but were not risk standardized. We also calculated unadjusted payments for transfer and nontransfer patients at non-PCI hospitals. We identified patients who underwent PCI either during index admission or readmission within the 30-day episode-of-care using ICD- 
Statistical Analysis
We performed a hospital-level analysis comparing the mean RSP for PCI hospitals with the mean RSP for non-PCI hospitals. We then performed the following patient-level analyses. We first calculated and compared procedure (PCI and CABG) and transfer rates for patients at PCI and non-PCI hospitals. In addition, we calculated and compared the rate of subsequent revascularizations that occurred after the index discharge but during the 30-day episode-of-care for patients admitted to PCI versus non-PCI hospitals. Procedures for patients who were readmitted within the 30-day episode-of-care but whose admissions extended beyond the end of the 30-day window were included in the subsequent revascularization outcome. We also calculated and compared mean unadjusted patient-level payments, including mean total payments, mean index hospital payments, and mean postacute care payments for patients presenting to PCI and non-PCI hospitals. In addition, we calculated and compared mean unadjusted payments for transfer and nontransfer patients who presented to non-PCI hospitals. A t test was used to compare RSPs, and χ 2 tests were used for dichotomous variables. We considered differences as statistically significant when P values were <0.05. All analyses were conducted using Stata/IC statistical software, version 11.1. We obtained institutional review board approval, including waiver of the requirement for participant informed consent, through the Yale University Human Investigation Committee.
Results
Patient Characteristics
Of the 180 375 AMI hospitalizations in 2008 included in this study, 137 427 (76.2%) were admissions to 1415 PCI hospitals and 42 948 (23.8%) to 2716 non-PCI hospitals. Baseline characteristics for patients initially admitted to PCI hospitals versus non-PCI hospitals are shown in Table 1 . Of note, patients presenting to PCI hospitals were younger than those presenting to non-PCI hospitals, with patients aged ≥85 years comprising only 26.3% of patients admitted to PCI hospitals as compared with 40.6% of those admitted to non-PCI hospitals. A greater percentage of patients presenting to PCI hospitals had previously undergone PCI when compared with those presenting to non-PCI hospitals (8.4% versus 5.3%, respectively), but a smaller percentage of patients admitted to PCI hospitals had previously undergone CABG (5.7% versus 7.1%, respectively). In addition, 28.6% of patients presenting to PCI hospitals had a history of congestive heart failure compared with 39.9% at non-PCI hospitals, and only 15.2% of patients presenting to PCI hospitals had a history of dementia as compared with 24.7% at non-PCI hospitals.
RSPs and Secondary Analyses
PCI hospitals had a higher mean 30-day RSP than non-PCI hospitals (PCI, $20 340; non-PCI, $19 713; P<0.001). The range of RSP was similar between PCI and non-PCI hospitals (PCI, $15 251-$27 317; non-PCI, $16 769-$24 597; Figure) .
To better understand the factors contributing to this difference in hospital-level payments, we identified the following patient-level patterns of care (Table 2) . Patients presenting to PCI hospitals had lower transfer rates (2.2% versus 25.4%; P<0.001) than those presenting to non-PCI hospitals. Patients presenting to PCI hospitals had higher PCI rates (39.2% versus 13.2%; P<0.001) and higher CABG rates (9.5% versus 4.4%; P<0.001) during the index admission than those presenting to non-PCI hospitals. Finally, the rate of subsequent revascularization within 30 days of the initial hospitalization was lower among patients who initially presented to PCI hospitals than to non-PCI hospitals (0.15% versus 0.27%; P<0.0001). To further investigate the differences in payments between patients who began their episode-of-care at PCI versus non-PCI hospitals, we examined unadjusted patient-level payments for the various care settings included in our calculations of hospital RSPs (Table 3) . Patients presenting to PCI hospitals had higher mean unadjusted index hospital payments ($16 111 versus $13 170) but lower mean unadjusted postacute care setting payments ($5046 versus $5894) than patients who initially presented to non-PCI hospitals. The difference in mean unadjusted payments for patients who were transferred from non-PCI hospitals compared with those who were not transferred was $12 166 ($27 198 versus $15 032).
Discussion
In this study of Medicare administrative claims, we found that PCI hospitals were associated with slightly higher costs for an episode-of-care for patients with AMI when compared with non-PCI hospitals. The difference is fairly modest-≈$600 for a 30-day period-and the percentage difference in cost is small, but when spread over the hundreds of thousands of beneficiaries with AMI each year, these cost differences could be meaningful. Nevertheless, it is important to determine whether this extra cost provides extra value, either through improved clinical outcomes, such as mortality or readmission, or improved patient satisfaction, function, or symptom burden.
There are several potential explanations for the differences in cost for AMI episodes initiated at PCI versus non-PCI hospitals. To understand factors that may account for the observed cost difference, we examined several patient-level patterns of care for patients admitted to PCI versus non-PCI hospitals. We found that patients who began their episode-of-care at PCI hospitals had higher PCI and CABG rates during the index admission than those initially admitted to non-PCI hospitals. Procedure rates may contribute substantially to higher costs. PCI indicates percutaneous coronary intervention; and SNF, skilled nursing facility.
*Mean total payments are price standardized but not risk standardized. †These are the percentages of total patients who were alive after the index admission and had ≥1 postacute care claims within the 30-day postadmission window.
‡Other inpatient payments include payments for inpatient psychiatry, inpatient rehabilitation, and long-term care hospitals.
However, patients initially admitted to non-PCI hospitals had substantially higher transfer rates and subsequent revascularization rates than patients initially admitted to PCI hospitals. Patients who are transferred accrue the cost of 2 hospitalizations, which may in part balance the cost of higher procedure rates at PCI hospitals. Similarly, the increased usage of postacute care resources by patients admitted to non-PCI hospitals adds to the cost of the 30-day episode-of-care initiated at non-PCI hospitals.
The results of this study are consistent with an earlier study conducted by this group, in which long-term costs and outcomes were examined for patients admitted to Connecticut hospitals with or without onsite cardiac catheterization facilities. 8 The study by Krumholz et al 8, 9 found no significant difference in hospital costs during the 3 years after the initial admission for patients admitted to hospitals with and without cardiac catheterization capability. Despite similar findings, the study variables differed substantially from those used in this study. This previous work was done for patients admitted between 1992 and 1993 in a single state, and costs were defined by each patient's hospital charge record and each hospital's Medicare cost-to-charge ratios. Conversely, our study evaluated the hospital-level payment made for Medicare patients admitted nationwide, and in the setting of growing numbers of PCI facilities in 2008.
Our finding that the cost of care at PCI and non-PCI hospitals is only modestly different affects recent discussions on regionalization of AMI care and establishment of new PCI programs. Many studies have considered whether regionalization of AMI care would benefit patients with AMI, but few, if any, have considered the cost implications of such a change in patient management. If AMI care were to be regionalized, patients with AMI who present to non-PCI hospitals would be immediately transferred to specialty regional centers with the capacity to perform PCI, without admission to non-PCI hospitals. Our findings suggest that sending all patients directly to PCI hospitals may slightly increase payments for Medicare patients admitted with AMI, and likely to be associated with increased PCI usage. Because patients who present with AMI may benefit from more rapid access to PCI, and in light of our findings that payments to PCI versus non-PCI hospitals do not differ dramatically, regionalization of AMI care may provide an efficient option for the treatment of these patients.
Although this work demonstrates that episodes-of-care arising at PCI hospitals are not substantially more expensive, the findings should not be interpreted to suggest that opening new PCI programs in the absence of an organized system for regionalization of care is a cost-effective strategy for AMI care. Several recent studies have shown that overall access to PCI has not changed in recent years, despite increased availability of PCI hospitals. 1, 5, 10 Moreover, the growth in the number of PCI hospitals has not led to improvements in time to treatment. 1 Furthermore, the evidence on mortality and readmission rates at PCI and non-PCI hospitals is not clear. Recent studies have shown that although mortality is lower on average for patients who present to PCI hospitals, there exists significant variation in mortality rates among PCI hospitals across the country, such that non-PCI hospitals may provide superior care to PCI hospitals in some areas. 3 This suggests that increasing the absolute number of PCI hospitals may not lead to improved care for patients with AMI.
This study has several limitations. First, we did not assess whether the modestly higher payment to PCI hospitals contributes to better outcomes for patients, including decreasing mortality and readmissions. The effect of admission to PCI versus non-PCI hospitals on patient mortality and readmission requires further investigation. We did not adjust for differences in the size of the hospitals or other hospital characteristics; it is possible that the difference in payment to PCI versus non-PCI hospitals may in part relate to these differences in hospital characteristics because PCI and non-PCI hospitals often differ in characteristics, such as urban versus rural setting, teaching versus nonteaching designations, and volume status. Our analysis of transfers included only those patients who were admitted to the initial presenting hospital and transferred to a second hospital; we were unable to analyze patients presented to the emergency department of one hospital before being transferred and admitted to a second hospital. In addition, we used Medicare admission data only, and results may not be applicable to the general population or other insurers, given different payment structures. However, Medicare is the country's largest insurer and Medicare patients make up a large proportion of patients with AMI. We did not include payments for Medicare part D drugs. Because patients who did not undergo PCI may rely more heavily on medical management than those who have undergone the procedure, excluding these payments may lower the average payment for non-PCI hospitals, the overall difference in payments between PCI and non-PCI hospitals was exaggerated. However, given a payment window of only 30 days, the added cost of medications is likely not substantial. Also, our study did not evaluate payments for patients with AMI that extended beyond the 30-day episodeof-care. Therefore, we did not account for those patients who underwent a procedure >30 days after their initial admission. Similarly, we did not account for payments accrued after 30 days attributable to outpatient care, skilled nursing facilities, hospice, or other services. Finally, our study does not address the question of what types of patients were more likely to be transferred from non-PCI hospitals to undergo PCI. Therefore, we were unable to appreciate whether highrisk patients who presented to PCI and non-PCI hospitals were treated similarly. It is possible that high-risk patients are transferred less often because of their unstable condition. Because patients who presented to non-PCI hospitals were generally older than those presenting to PCI hospitals, and therefore at higher risk of complication during transfer, this may contribute in part to the lower procedure rates attributed to non-PCI hospitals.
In conclusion, this study demonstrates that despite increased PCI and CABG rates for patients who begin their 30-day episode-of-care at PCI hospitals, hospital-level payments to PCI hospitals are only modestly higher than hospital-level payments to non-PCI hospitals for the treatment of patients with AMI.
